⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Lyo Innovation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Lyo Innovation
↗Hong Kong, China
Lyo Innovation is a specialized provider of lyophilization (freeze-drying) solutions, equipment, and services for the biopharmaceutical, pharmaceutical, and healthcare industries. The company offers formulation characterization, cycle development, technology transfer, and small-batch production services, alongside proprietary equipment such as freeze dryers, lyobead dispensing systems, and analytical instruments.
Originally spun off from the Tegent Group (established in 1992), Lyo Innovation leverages decades of experience in laboratory equipment and freeze-drying technology. The company operates through entities in Hong Kong and Shanghai, focusing on enabling innovation in the development of biologics, vaccines, ATMPs, and diagnostic products.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2022
Ownership:private
Status:operating
PIPELINE
Stage:N/A
Lead Drug Stage:N/A
Modalities:Peptides, Proteins, Oligonucleotides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Tegent Group
Subsidiaries:Lyo Innovation Biotech (Shanghai) Co., Ltd.
COMPETITION
Position:Niche Player
Competitors:SP Scientific, IMA Life, Martin Christ, Telstar
LINKS
Website:lyoinnovation.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Lyo Innovation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.